Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease
Elbatanouny, M., Abdelaal, O., Mohammad, M. (2022). Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease. EKB Journal Management System, 3(3), 213-221. doi: 10.21608/ejmr.2022.259165
Mahmoud Mohamed Elbatanouny; Osama Ahmed Abdelaal; Mohammad Farouk Mohammad. "Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease". EKB Journal Management System, 3, 3, 2022, 213-221. doi: 10.21608/ejmr.2022.259165
Elbatanouny, M., Abdelaal, O., Mohammad, M. (2022). 'Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease', EKB Journal Management System, 3(3), pp. 213-221. doi: 10.21608/ejmr.2022.259165
Elbatanouny, M., Abdelaal, O., Mohammad, M. Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease. EKB Journal Management System, 2022; 3(3): 213-221. doi: 10.21608/ejmr.2022.259165

Studying Microalbuminuria In Patients With COPD In Relation To The New Version Of Global Initiative For Chronic Obstructive Lung Disease

Egyptian Journal of Medical Research
Volume 3, Issue 3, July 2022, Page 213-221  XML PDF (371.2 K)
Document Type: Original Article
DOI: 10.21608/ejmr.2022.259165
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud Mohamed Elbatanouny; Osama Ahmed Abdelaal; Mohammad Farouk Mohammad
Chest and Tuberculosis department, Faculty of Medicine, Beni-Suef University, Egypt
Abstract
Background: Microalbuminuria, used as a marker of endothelial dysfunction, is a predictor of mortality and of cardiovascular events. Microalbuminuria (MAB) in chronic obstructive lung disease (COPD) is attributed to generalized endothelial dysfunction as a result of systemic inflammation, which could be a significant marker for early cardiovascular abnormality. Objectives: Study the relationship between microalbuminuria and disease class in subjects with COPD classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 “A, B, C, D” classification in absence of hypertension and diabetes ,and to Evaluate the clinical features that may predict cardiovascular risk in subjects with COPD. Setting: Chest Department and outpatient clinic, Beni-Suef University Hospital. Methods: Prospective Study included 60 patients who were diagnosed as COPD by Pulmonary function tests. All patients were subjected to clinical examination, Chest x ray, spirometry  and Urinary albumin/creatinine ratio. Results: Urinary albumin/creatinine ratios were significantly higher in subjects who have more symptoms and high future risk (categories C, D) than in those with fewer symptoms and low future risk (categories A, B). A Significant differences were noted when the subjects were grouped based on PaO2 (<65mmHg versus >65mmHg), PaCO2 (<41mmHg versus >41mmHg), arterial oxygen saturation (<92% versus >92%), FEV1 (median split <60% versus >60%). There was a statistically significant strong negative correlation between the alb/creat ratio and FEV1% (r=-0.937, p=0.000), PaO2 (r=-0.929, p=0.000) and SaO2(r=-0.934,p=0.000). There was a statistically significant strong positive correlation between the alb/creat ratio and Severity of COPD Gold categories (r=0.931, p=0.000), PaCO2 (r=0.930, p=0.000) and number of hospital admissions last year (r=0.946, p=0.000). There was a highly significant association between high level alb/creat ratio and the presence of pulmonary hypertension (P <0.001). Conclusions: There is a strong correlation between microalbuminuria and the new version of GOLD A, B, C and D classification. Because the diagnosis of microalbuminuria is simple, inexpensive, and noninvasive, it can be evaluated routinely in COPD cases, especially those with many symptoms who are at higher risk, to early predict cardiovascular morbidity and mortality.
Keywords
Copd Severity; Microalbuminuria
References
  1. Mannino DM and Buist AS. (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet; 370(9589):765-773.
  2. Ghoorah K, De Soyza A and Kunadian V. (2013) Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. Cardiol Rev; 21(4):196–202.
  3. Weir MR.(2007) Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol; 2:581–590.
  4. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, et (2004) Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria. Am J Cardiol ; 94(3):294-299.
  5. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for end point reduction in hypertension study. Hypertension; 45(2):198-202.
  6. Barr RG, Mesia-Vela S, Austin JHM, Basner RC, Keller BM, Reeves AP, Shimbo D and Stevenson L. (2007) Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers. Am J Respir Crit Care Med; 176:1200–1207.
  7. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C and Yenicerioglu Y. (2008) Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis; 26(2):97–102.
  8. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (2016) http://goldcopd.org/globalstrategy-diagnosis-management-prevention-copd-2016.
  9. Ko¨mu¨rcuog˘lu A, Kalenci S, Kalenci D, Ko¨mu¨rcu¨og˘lu B and Tibet G. (2003) Microalbuminuria in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis; 59(4):269-272.
  10. Mehmood K and Sofi FA.(2015) Microalbuminuria and hypoxemia in patients with COPD. J Pulm Respir Med; 5:280.
  11. Casanova C, deTorres JP, Navarro J, Aguirre- Jaíme A, Toledo P, Cordoba E, et al. (2010) Microalbuminuria and hypoxia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med; 182(8):1004–1010.
Statistics
Article View: 215
PDF Download: 193